作者
Nikhil C. Munshi,Larry D. Anderson,Nina Shah,Deepu Madduri,Jesús G. Berdeja,Sagar Lonial,Noopur Raje,Yi Lin,David S. Siegel,Albert Oriol,Philippe Moreau,Ibrahim Yakoub‐Agha,Michel Delforge,Michèle Cavo,Hermann Einsele,Hartmut Goldschmidt,Katja Weisel,Alessandro Rambaldi,Donna Reece,Fabio Petrocca,Mónica Massaro,Jamie N. Connarn,Shari M. Kaiser,Payal Patel,Liping Huang,Timothy B. Campbell,Kristen Hege,Jesús F. San Miguel
摘要
Idecabtagene vicleucel (ide-cel, also called bb2121), a B-cell maturation antigen–directed chimeric antigen receptor (CAR) T-cell therapy, has shown clinical activity with expected CAR T-cell toxic effects in patients with relapsed and refractory multiple myeloma.
酸化土壤改良
gjww
rocky15
寻道图强
shinysparrow
Solomon
热切菩萨
leexk
Singularity
DY
凤凰
天才小能喵
maox1aoxin
pluto
从容芮
hwx431
不热心小伙伴
柯一一
Caesar
tramp
皖公网安备34019202002308
